Aligos Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $0.00.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$47.00K.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $46.00K.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$133.00K.
- Aligos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2021 was -$245.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$47.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$47.00K 10-Q · filed 2026-05-07 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $46.00K 10-K · filed 2025-03-10 | ||
| 2023-09-30 | $46.00K 10-Q · filed 2024-11-06 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | -$133.00K 10-K · filed 2024-03-12 | |||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-04 | -$133.00K derived: sum of 2 quarters · filed 2023-05-04 | -$132.00K derived: sum of 3 quarters · filed 2023-05-04 | -$133.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$133.00K derived: sum of 2 quarters · filed 2023-03-09 | -$134.00K derived: sum of 3 quarters · filed 2023-03-09 | -$245.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | -$111.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$112.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$111.00K 10-Q · filed 2022-05-04 |